New candidate vaccines for variants designed

2022-04-07 10:53:44China Daily Editor : Li Yan ECNS App Download
Special: Battle Against Novel Coronavirus

Chinese scientists have described a new strategy for making vaccines against COVID-19 that could elicit effective neutralizing antibodies against the Omicron and Delta variants.

Researchers led by Wei Wensheng from Peking University have developed a platform to produce next-generation vaccine design or circular RNA (circRNA) vaccines.

The spike protein of the virus that causes COVID-19 has been used as the primary target of mRNA vaccines. But those vaccines with a linear RNA structure tend to miss the target in neutralizing emerging variants.

The circRNA vaccines with a closed ring structure are more stable than mRNA vaccines, thus inducing more potent humoral and cellular immune responses, according to the study recently published in the journal Cell.

They are shown to elicit a high proportion of neutralizing antibodies, and enable effective protection against SARS-CoV-2 in mice and rhesus macaques.

Furthermore, the vaccines can produce a kind of protective T cell response, which could effectively reduce the risks of potential vaccine-associated enhanced respiratory diseases, the researchers said.

The study showed that one vaccine of this kind targeting Omicron induced effective neutralizing antibodies against Omicron but not the Delta variant, while another vaccine targeting Delta protected against both Delta and Omicron or functioned as a booster after two doses of vaccination.

Therefore, the researchers suggested the circRNA-Delta vaccine could be developed into broad-spectrum candidate vaccines.

Related news


Most popular in 24h

MoreTop news


Back to top About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2022 All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证(0106168)] [京ICP证040655号]
[京公网安备 11010202009201号] [京ICP备05004340号-1]